Menadiol sodium diphosphate

Kappadione, Synkayvite (menadiol sodium diphosphate) is a small molecule pharmaceutical. Menadiol sodium diphosphate was first approved as Kappadione on 1982-01-01.

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

154 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

No data

Indications Phases 3

No data

Indications Phases 2

No data

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Psoriasis	D011565	EFO_0000676	L40	2	—	—	—	—	2
Healthy volunteers/patients	—	—	—	1	—	—	—	—	1

Indications Without Phase

No data

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	Menadiol sodium diphosphate
INN	_
Description	Kappadione, Synkayvite (menadiol sodium diphosphate) is a small molecule pharmaceutical. Menadiol sodium diphosphate was first approved as Kappadione on 1982-01-01.
Classification	Small molecule
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	Cc1cc(OP(=O)([O-])[O-])c2ccccc2c1OP(=O)([O-])[O-].O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+]